ReviewCurrent hypertension reports2026
Circadian Systems and Neural Control of Blood Pressure.
Review in Current hypertension reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purpose of reviewBlood pressure (BP) follows a robust circadian rhythm and disruption of this rhythm is associated with hypertension and increased cardiovascular disease risk. This review discusses the current understanding of how circadian mechanisms regulate the neural control of BP, with a focus on autonomic brain circuits, local molecular clocks, and emerging neuroimmune mechanisms contributing to the regulation of BP. RECENT
findingsNumerous studies show that autonomic control areas of the brainstem are important for circadian BP regulation. Regions such as the rostral ventrolateral medulla (RVLM), the nucleus tractus solitarius (NTS), and paraventricular nucleus of the hypothalamus (PVN) all contain intrinsic molecular clocks that play a role in sympathetic activity and baroreflex function. Emerging evidence also indicates that disruption of clock function in microglia within the RVLM acts as a potential mechanism that contributes to neuroinflammation, sympathetic overactivity, and non-dipping hypertension. The growing interest in chronotherapy, renal denervation, and ambulatory BP monitoring emphasizes the clinical importance of circadian BP regulation. Circadian regulation of BP is comprised of coordinated interactions between the SCN, autonomic neural circuits, and local molecular clocks. Disruptions in any of these mechanisms lead to abnormalities in BP rhythms increasing the risk of hypertension. Despite recent advances, many questions remain regarding the relative contributions of central and peripheral clocks, the causal role of circadian disruption in hypertension, and the mechanisms underlying sex differences. Addressing these gaps may identify new approaches for preventing and treating hypertension by targeting circadian regulation of cardiovascular function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.